The category of illness that produces physical symptoms with no identifiable disease or organic cause is called somatic symptom and related disorders, including somatic symptom disorder, illness anxiety disorder, and conversion disorder. These conditions are defined by distressing body symptoms plus abnormal thoughts, feelings, and behaviors about them, not by the absence of disease alone. The current edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) removed the old requirement that symptoms be "medically unexplained."
How the brain generates real body symptoms
Somatic symptoms are not imagined. The brain's predictive processing model says perception is a controlled hallucination. The cortex constantly predicts what the body should feel and corrects that prediction against incoming sensory signals. When attention narrows onto a body region, the precision weighting on those signals rises, and ordinary noise (muscle tension, gut motility, mild arrhythmia) gets amplified into a conscious symptom. This is why anxiety produces a genuinely racing heart and why chronic pain persists after tissue heals.
The autonomic nervous system supplies the second pathway. Sympathetic activation raises heart rate, blood pressure, and muscle tension, and shifts blood flow away from the gut. Sustained activation produces chest tightness, trembling, and nausea that are physiologically measurable but not evidence of organ disease. The hypothalamic-pituitary-adrenal axis adds cortisol-driven fatigue and immune changes.
A third pathway operates through the default mode network and insula, regions tied to body awareness and self-referential thought. Overactivity here predicts symptom persistence independent of medical findings. Conversion symptoms, such as weakness or sensory loss without nerve damage, arise from disrupted motor and sensory predictions rather than damaged tracts.
Quantified context
Somatic symptom disorder appears in roughly 5 to 7 percent of adults in general populations, according to pooled international studies. In primary care, estimates run from 10 to 20 percent, and some European samples exceed 20 percent. Conversion disorder has a lower prevalence, commonly estimated at 1 to 3 percent of general populations, though it is far more common in neurology clinics.
Somatic symptom disorder is diagnosed about twice as often in women as in men. Onset is most common between ages 25 and 44, though symptoms can begin earlier. The disorder accounts for substantial health care use: repeated consultations, imaging, and referrals before diagnosis. Symptoms typically persist for years; in follow-up studies, remission within 12 months occurs in a minority of patients, while many show intermittent improvement.
Edge cases that look somatic but are not
The first rule of this diagnosis is ruling out organic disease. Multiple sclerosis, early Parkinson's disease, thyroid disease, celiac disease, lupus, and myasthenia gravis all produce symptoms that can precede objective findings by months or years. A misdiagnosed conversion disorder carries the same harm as a missed myocardial infarction. The diagnosis requires a reasonable workup, not exhaustive testing, and should never rest on a single normal scan.
Functional neurological disorder (FND) is the modern umbrella term for conversion symptoms. It is not a diagnosis of exclusion. FND has positive signs: Hoover's sign in leg weakness, tremor entrainment, and inconsistency across examination. Neurologists use these signs to diagnose, not merely to exclude.
Another edge case is somatic symptoms with a true medical cause plus disproportionate distress. A patient with diabetes can have genuine neuropathy and also meet criteria for somatic symptom disorder. DSM-5-TR deliberately allows both diagnoses, because the disorder is defined by the response to symptoms, not the symptoms themselves.
Misconceptions about "medically unexplained" symptoms
The biggest misconception is that no organic cause means the symptom is fake. It does not. The symptom is real, measurable in many cases, and disabling. The problem is the brain's processing of body signals, not invented complaint.
A second misconception is that somatic symptom disorder equals hypochondria. Illness anxiety disorder describes people with high health anxiety but few or no actual symptoms; somatic symptom disorder describes high symptom burden with high distress. The two overlap but are distinct.
A third misconception is that a psychological explanation is a soft diagnosis. Functional imaging shows altered connectivity in pain-processing networks in somatic symptom disorder, and FND has objective exam signs. These are brain-based disorders with measurable features, not moral or character judgments.
A fourth misconception is that these patients are "attention seeking." Most meet criteria for depression or an anxiety disorder, not antisocial traits, and many seek care because they are frightened, not because they seek drugs or drama.
Practical actions and thresholds
Red flag: new neurologic deficit with a sudden onset requires emergency evaluation before any psychiatric framing. Call local emergency services for stroke signs, chest pain, or suicidal ideation. Red flag: unexplained weight loss, night sweats, fever, or bleeding during symptom workup points to organic evaluation first. Schedule a consistent, brief follow-up interval (every 4 to 6 weeks) rather than symptom-dependent visits; this reduces unnecessary testing. Ask for a single coordinating clinician and a written care plan, then limit repeat imaging to cases where it changes management. For FND, request a neurologist with functional disorder expertise and referral to physical or cognitive behavioral therapy. Address sleep, alcohol, and stimulant use, because each independently amplifies autonomic symptoms.
Recognize that the diagnosis does not exempt a patient from future disease. Symptoms can evolve into a new organic illness, so persistent or changing symptoms warrant reassessment.
Comparison: somatic symptom vs. related diagnoses
| Syndrome | Core feature | Symptom count | Distress about health | Typical prevalence | Key distinction |
|---|---|---|---|---|---|
| Somatic symptom disorder | Distressing symptoms plus excessive thoughts or behaviors | ≥1 symptom | High | 5–7% of adults | Symptoms are present, not just feared |
| Illness anxiety disorder | Preoccupation with having a serious illness | Few or none | Very high | ~1–2% | Fear dominates; symptoms minimal |
| Conversion disorder (FND) | Altered motor or sensory function without disease | Variable | Variable | ~1–3% | Objectively inconsistent findings |
| Factitious disorder | Intentional falsification for sick role | Variable | Low to high | Rare in clinic | Deception is the defining feature |
| Normal illness behavior | Stress-related symptoms | Low | Age-appropriate | Very common | Does not impair function |
The table's central message is that symptom burden, not the absence of pathology, drives diagnosis. Distinguishing somatoform conditions from factitious disorder matters clinically: the former involves no intent to deceive.
Timeline of typical diagnosis and care
| Stage | Usual timeframe | What happens | Clinician action |
|---|---|---|---|
| Symptom onset | Day 1 to weeks | Symptoms appear, often after stress or illness | Listen, record red flags |
| Initial workup | Weeks 1–6 | Basic labs, focused imaging based on findings | Exclude common organic causes |
| Referral phase | Weeks 4–16 | Specialist referrals multiply | Coordinate to avoid duplication |
| Diagnosis | Months 3–12 | Pattern recognized as somatic or functional | Explain without dismissing |
| Treatment start | Months 3–18 | CBT, physiotherapy, or coordinated care | Set realistic goals |
| Follow-up plateau | Year 1+ | Symptoms fluctuate, function improves | Maintain scheduled visits |
Timelines vary widely. Some patients receive the diagnosis within weeks; others accumulate years of testing. Earlier recognition correlates with lower health care cost and less iatrogenic harm.
Limitations
The evidence base for these disorders is smaller than for major depression, and treatment trials are heterogeneous. Cognitive behavioral therapy has the strongest evidence, but effect sizes vary and access is limited in many regions. No medication is approved for somatic symptom disorder specifically; antidepressants are used for co-occurring mood or anxiety disorders but do not carry an indication for the somatic syndrome itself.
Diagnosis depends on clinical judgment. There is no biomarker, and the line between normal worry and disorder is set by function and distress, not by a lab value. This leaves room for both underdiagnosis (missing real disease) and overdiagnosis (dismissing real disease). The DSM-5-TR change toward positive criteria was meant to reduce stigma, but stigma persists in many clinical settings.
Finally, the phrase "no organic cause" is a historical convenience, not a settled scientific claim. Functional disorders are brain-body disorders, and future research may identify measurable mechanisms that reclassify some patients. Until then, treatment rests on careful exclusion, positive diagnostic signs, education, and coordinated care.
This article provides general educational information, not a diagnosis or treatment plan. It is not a substitute for consultation with a qualified clinician who can review your individual history and current medications. If you or someone else is in immediate danger from symptoms or thoughts of self-harm, contact local emergency services or a crisis line right away.